Citation Impact
Citing Papers
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
No health without mental health
2007 Standout
Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction
1992
Ribosomal drug resistance in mycobacteria
1996
Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates
2006
Multiple Interacting Sites of Ectopic Spike Electrogenesis in Primary Sensory Neurons
2005
Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease
2002
Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in mice
1995 Standout
Disseminated Mycobacterium scrofulaceum Infection: A Potentially Treatable Complication of AIDS
1995
NONTUBERCULOUS MYCOBACTERIAL INFECTIONS
1997
The Role of Advanced Generation Macrolides in the Prophylaxis and Treatment of Mycobacterium avium Complex (MAC) Infections
1997
Hyperexcitability in sensory neurons of rats selected for high versus low neuropathic pain phenotype
2001
A Prospective, Randomized Trial Examining the Efficacy and Safety of Clarithromycin in Combination with Ethambutol, Rifabutin, or Both for the Treatment of Disseminated Mycobacterium avium Complex Disease in Persons with Acquired Immunodeficiency Syndrome
2003
Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence
1993 Standout
A Comparison of Two Regimens for the Treatment ofMycobacterium aviumComplex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and Ciprofloxacin
1996
Azithromycin Activity Against Mycobacterium avium Complex Lung Disease in Patients Who Were Not Infected with Human Immunodeficiency Virus
1996
Molecular Mechanisms of Clarithromycin Resistance in Mycobacterium avium: Observation of Multiple 238 rDNA Mutations in a Clonal Population
1996
Treatment of severe Crohn's disease using antimycobacterial triple therapy — approaching a cure?
2002
Once Weekly Azithromycin Therapy for Prevention ofMycobacterium aviumComplex Infection in Patients with AIDS: A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Trial
1998
Antituberculosis drugs: Ten years of research
2007
Induction of peripheral CD8+ T‐cell tolerance by cross‐presentation of self antigens
1998 StandoutNobel
THE FUNCTION OF γδ T CELLS
1992 StandoutNobel
Programmes and principles in treatment of multidrug-resistant tuberculosis
2004
Spared nerve injury: an animal model of persistent peripheral neuropathic pain
2000 Standout
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
2011 Standout
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
2010 Standout
Heat-shock proteins and pathogenesis of bacterial infections
1991
Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, 'Israeli spotted fever group rickettsia' and Coxiella burnetii
1997
The role of injury discharge in the induction of neuropathic pain behavior in rats
1991
Sequential assembly of the septal cell envelope prior to V snapping in Corynebacterium glutamicum
2019 StandoutNobel
Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents
2011 StandoutNobel
Structural Basis for the Antibiotic Activity of Ketolides and Azalides
2003 StandoutNobel
Specific inhibition of phagosome-lysosome fusion in murine macrophages mediated bySalmonella typhimuriuminfection
1990
Persistent postsurgical pain: risk factors and prevention
2006 Standout
Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates
1991
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics
1997
Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials
2001
Ribosomal antibiotics: structural basis for resistance, synergism and selectivity
2004 StandoutNobel
Heritability of symptoms in an experimental model of neuropathic pain
1990
Antimicrobial peptides of multicellular organisms
2002 StandoutNature
How antibiotics kill bacteria: from targets to networks
2010 Standout
Neuropathic pain: aetiology, symptoms, mechanisms, and management
1999 Standout
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
2014
Clinical and Molecular Analysis of Macrolide Resistance in Mycobacterium avium Complex Lung Disease
2006
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
The Macrolides: Erythromycin, Clarithromycin, and Azithromycin
1999
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
1993 Standout
Immunology of Tuberculosis
2001 Standout
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
Biological Activities of Hydrazone Derivatives
2007 Standout
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.
1992 Standout
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease
1995
A journey across the sequential development of macrolides and ketolides related to erythromycin
2005
Nanotechnology innovations for the construction industry
2013 Standout
Q Fever
1999 Standout
Bacteria-Targeting Nanoparticles with Microenvironment-Responsive Antibiotic Release To Eliminate Intracellular Staphylococcus aureus and Associated Infection
2018
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Novel Diagnostic Algorithm for Identification of Mycobacteria Using Genus-Specific Amplification of the 16S-23S rRNA Gene Spacer and Restriction Endonucleases
2000 Standout
Common themes in microbial pathogenicity revisited
1997 Standout
A Concise History of Mycotoxin Research
2016
Killing ofMycobacterium tuberculosiswithin human monocytes: activation by cytokines and calcitriol
1991
Antimycobacterial Agent Based on mRNA Encoding Human β-Defensin 2 Enables Primary Macrophages To Restrict Growth ofMycobacterium tuberculosis
2001
NITRIC OXIDE AND MACROPHAGE FUNCTION
1997 Standout
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
rpoB -Based Identification of Nonpigmented and Late-Pigmenting Rapidly Growing Mycobacteria
2003 Standout
Emergence of a Unique Group of Necrotizing Mycobacterial Diseases
1999
Risk factors for human disease emergence
2001 Standout
Worldwide contamination of food-crops with mycotoxins: Validity of the widely cited ‘FAO estimate’ of 25%
2019 Standout
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis
1993
Intracellular pharmacokinetics of telithromycin, a ketolide antibiotic, in alveolar macrophages
2010
Indoor Mold, Toxigenic Fungi, andStachybotrys chartarum: Infectious Disease Perspective
2003
ETCM: an encyclopaedia of traditional Chinese medicine
2018 Standout
Nocardia species: host-parasite relationships
1994 Standout
Epidemiology of infection by nontuberculous mycobacteria
1996
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus
1996
Receptor-Mediated Uptake of Antigen/Heat Shock Protein Complexes Results in Major Histocompatibility Complex Class I Antigen Presentation via Two Distinct Processing Pathways
1999 StandoutNobel
The timing of exposure of mononuclear phagocytes to recombinant interferon γ and recombinant tumor necrosis factor α alters interactions with Nocardia asteroides
1992
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis.
1995
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium
1997 Standout
Constitutive class I-restricted exogenous presentation of self antigens in vivo.
1996 StandoutNobel
The Continuing Challenges of Leprosy
2006 Standout
Mycobacterium leprae renders Schwann cells and mononuclear phagocytes susceptible or resistant to killer cells
1991
Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies
1996
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
1993 Standout
Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation
1986
Works of N Mor being referenced
Alimentary toxic aleukia (septic angina, endemic panmyelotoxicosis, alimentary hemorrhagic aleukia): t-2 toxin-induced intoxication of cats.
1981
Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages
1997
Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages
1995
Discrepancy in assessment of phagosome-lysosome fusion with two lysosomal markers in murine macrophages infected with Candida albicans
1987
Bacteriostatic and bactericidal activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophages
1996
Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium
1994
Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages
1994
Mycobacterium lepraemurium activates macrophages but fails to trigger release of superoxide anion.
1988
Enhancement of growth of Mycobacterium lepraemurium in macrophages by gamma interferon
1989
Multiplication of Mycobacterium marinum within phagolysosomes of murine macrophages
1985
MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages
1993
Mycobacterium avium strains resistant to clarithromycin and azithromycin
1993
Intracellular location of Mycobacterium leprae in macrophages of normal and immune-deficient mice and effect of rifampin
1983
The Sabra rat: definition of a laboratory animal.
1984